Wall Street Journal (press release) Operating and Capital Cost Estimates - Preliminary capital and operating costs were developed using information available from other Nevada heap leach operations, a commercially available mining and development cost database, plus all available project ... and more »
Stockhouse Further focused leach testing with optimization and closed cycle testing of representative samples needs to be done to confirm reagent consumptions and to achieve enhanced Mg recoveries to solution. No actual production of fused magnesia from West High ... and more »
Linex Legal (registration) (press release) 540-41. Class I devices would be subject to various general postmarket controls (e.g., establishment registration, device listing, good manufacturing practice, or GMP). Class II devices would be subject to FDA established performance standards and ...
Sacramento Bee Ventana Medical Systems, Inc. ("VMSI") (SIX: RO, ROG; OTCQX: RHHBY), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA solutions are used ... and more »
4-traders (press release) BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents . The...
Fort Mills Times BioTime intends to use the net proceeds from the offering for working capital and other general corporate purposes, and may invest a portion of the proceeds in one or more of its subsidiaries, including funding of the expansion of the LifeMap Sciences ... and more »
